Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Imaging biomarkers of progressive mitochondrial dysfunction in in vitro models of retinal neurodegeneration

Tiffany Heaster-Ford; Pooja Teotia; Carmela Louise M. Villegas; Marion Jeanne; Justin Elstrott

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2507.

ARVO Annual Meeting Abstract June 2024

Collagen Type VIII alpha 1 (COL8A1) knockout mice have exacerbated choroidal neovascular lesions and incomplete response to anti-VEGF therapy

Xiaowu Gu; Tom Truong; Yann Malato; Shawnta Yvonne Chaney; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2212.

ARVO Annual Meeting Abstract June 2024

A microfluidic platform for medium-throughput analysis of axonal degeneration in human retinal ganglion cells

Pooja Teotia; Carmen Sandoval; Tiffany Heaster-Ford; Michelle Chen; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6761.

ARVO Annual Meeting Abstract June 2023

Characterization of microglial and retinal ganglion cell changes following optic nerve crush in CD11c.YFP.Venus mice

Xiaowu Gu; Gyeong Jin Kang; TOM TRUONG; Tiffany Heaster; Joanna Yung; Jeffrey Eastham; Jeffrey Hofmann; Shawnta Yvonne Chaney; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1599.

ARVO Annual Meeting Abstract June 2023

Human pluripotent stem cell-derived retinal ganglion cells and their potential to study axonal degeneration in glaucomatous optic neuropathy

Pooja Teotia; Carmen Sandoval; Melissa Kaye Jones; Tao Sun; Tiffany Heaster; Fatima Abbas; Michelle Chen; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1560.

ARVO Annual Meeting Abstract June 2023

Effects of Caspase 3 and 7 knockout on cell death in in vivo and in vitro AMD models

Fatima Abbas; Han Qin; TOM TRUONG; Shawnta Chaney; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2717.

ARVO Annual Meeting Abstract June 2023

Transcriptomic comparison of in vitro and in vivo models for retinal dystrophy

Melissa Kaye Jones; Luz Orozco; Han Qin; Tom Truong; Justin Elstrott; Zora Modrusan; Shawnta Chaney; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3198.

ARVO Annual Meeting Abstract July 2018

CIDEC genetic variants identified in slow progressing Age-related Macular Degeneration patients affect lipid droplet formation

Sehyun Kim; Han Qin; Amy Dressen; Patrick Chang; Meredith Sagolla; Justin Elstrott; Brian Yaspan; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2432.

ARVO Annual Meeting Abstract July 2018

Human stem cell-derived cells and organoids are relevant in vitro systems to understand maculapothy pathogenesis

Han Qin; Sehyun Kim; Zhe Li; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4590.

ARVO Annual Meeting Abstract June 2015

Identification of genetic modifier underlying COL4A1-related anterior segment dysgenesis in mice

Mao Mao; Marion Jeanne; Tanav Popli; Kendall Hoff; Saunak Sen; Douglas B Gould

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3662.

ARVO Annual Meeting Abstract June 2013

Allelic Heterogeneity Contributes to Variability in Ocular Dysgenesis, Myopathy, and Brain Malformations Caused by Col4a1 and Col4a2 Mutations

Debbie Kuo; Cassandre Labelle-Dumais; Mao Mao; Marion Jeanne; William Kauffman; Jennifer Allen; Jack Favor; Douglas Gould

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1347.

ARVO Annual Meeting Abstract March 2012

Allelic influence of Col4a1 and Col4a2 in anterior segment dysgenesis in mice

Mao Mao; Debbie Kuo; Cassandre Labelle-Dumais; Marion Jeanne; Jack Favor; Douglas B. Gould

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4923.

Advertisement